Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.6 USD | -0.43% | +4.26% | -14.16% |
Jul. 10 | Jazz Pharmaceuticals plc Promotes Samantha Pearce to Chief Commercial Officer | CI |
Jul. 09 | RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.16% | 6.66B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals Public Limited Company Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 09